Yesterday fellow poster Mjc159 posted this passage below that I thought was worth re-highlighting....(thanks Mjc159!)
From a previous ADO presentation.
Due to sensitivity limitations, only 2,000 serum proteins are routinely analysed. There are about 100,000 serum proteins believed to exist in human blood which are not analysed due to limitations in existing assays - Mix&Go removes these limitations.
That opens up the potentially 'exclusive' new tests for first movers like Alere.
Once the market gets its head around this statement alone, they will realise the sheer potential of Mix&Go and its enormous value.
Regards,
Tony
ado the real deal $200 - $300m mcap coming, page-29
-
- There are more pages in this discussion • 105 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
